Clifford Swan Investment Counsel’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5M Sell
103,217
-1,136
-1% -$308K 0.94% 32
2025
Q4
$26.2M Sell
104,353
-1,870
-2% -$497K 0.87% 34
2025
Q3
$30.5M Buy
106,223
+2,216
+2% +$594K 1.01% 27
2025
Q2
$27.3M Buy
104,007
+2,299
+2% +$560K 0.96% 32
2025
Q1
$23.7M Buy
101,708
+3,712
+4% +$901K 0.88% 36
2024
Q4
$22.5M Buy
97,996
+1,614
+2% +$370K 0.81% 38
2024
Q3
$21.5M Buy
96,382
+10,384
+12% +$2.28M 0.76% 40
2024
Q2
$17.5M Buy
85,998
+3,563
+4% +$725K 0.65% 50
2024
Q1
$18M Buy
82,435
+1,087
+1% +$239K 0.67% 49
2023
Q4
$18.5M Buy
81,348
+5,309
+7% +$1.12M 0.72% 45
2023
Q3
$15.3M Sell
76,039
-5,343
-7% -$1.13M 0.64% 48
2023
Q2
$16.9M Buy
81,382
+4,991
+7% +$968K 0.68% 47
2023
Q1
$15.1M Sell
76,391
-562
-0.7% -$116K 0.63% 53
2022
Q4
$15.6M Buy
76,953
+2,275
+3% +$445K 0.68% 48
2022
Q3
$13.1M Buy
74,678
+2,309
+3% +$473K 0.62% 53
2022
Q2
$14.6M Buy
72,369
+4,679
+7% +$997K 0.63% 50
2022
Q1
$15.3M Sell
67,690
-184
-0.3% -$43.3K 0.57% 51
2021
Q4
$18.3M Buy
67,874
+194
+0.3% +$48K 0.64% 45
2021
Q3
$16.8M Sell
67,680
-1,563
-2% -$394K 0.62% 46
2021
Q2
$17.9M Sell
69,243
-15
-0% -$3.42K 0.68% 44
2021
Q1
$15.2M Buy
69,258
+109
+0.2% +$21.9K 0.62% 48
2020
Q4
$12.1M Sell
69,149
-1,948
-3% -$336K 0.53% 60
2020
Q3
$11.5M Buy
71,097
+4,011
+6% +$636K 0.55% 55
2020
Q2
$9.57M Buy
67,086
+5,785
+9% +$800K 0.49% 66
2020
Q1
$6.66M Buy
61,301
+8,633
+16% +$1.24M 0.4% 77
2019
Q4
$7.65M Buy
52,668
+775
+1% +$112K 0.37% 83
2019
Q3
$7.49M Buy
51,893
+2,077
+4% +$303K 0.39% 80
2019
Q2
$7.4M Sell
49,816
-145
-0.3% -$20.2K 0.39% 81
2019
Q1
$6.57M Buy
49,961
+22,960
+85% +$2.83M 0.35% 86
2018
Q4
$2.93M Buy
27,001
+1,490
+6% +$200K 0.18% 105
2018
Q3
$3.81M Buy
25,511
+5
+0% +$761 0.2% 105
2018
Q2
$3.93M Hold
25,506
0.22% 104
2018
Q1
$3.54M Sell
25,506
-116
-0.5% -$17K 0.2% 107
2017
Q4
$3.51M Hold
25,622
0.19% 108
2017
Q3
$3.32M Sell
25,622
-116
-0.5% -$15.5K 0.2% 108
2017
Q2
$3.41M Sell
25,738
-454
-2% -$55.6K 0.21% 107
2017
Q1
$3.23M Sell
26,192
-1,294
-5% -$153K 0.21% 104
2016
Q4
$3.03M Buy
27,486
+94
+0.3% +$10.4K 0.2% 105
2016
Q3
$3.23M Sell
27,392
-3,049
-10% -$359K 0.22% 101
2016
Q2
$3.41M Sell
30,441
-3,826
-11% -$412K 0.24% 92
2016
Q1
$3.45M Sell
34,267
-931
-3% -$89.3K 0.23% 92
2015
Q4
$3.74M Buy
35,198
+2,182
+7% +$225K 0.26% 87
2015
Q3
$3.08M Sell
33,016
-902
-3% -$93.3K 0.22% 93
2015
Q2
$3.53M Sell
33,918
-4,007
-11% -$417K 0.24% 92
2015
Q1
$4.11M Sell
37,925
-6,164
-14% -$634K 0.27% 84
2014
Q4
$4.09M Buy
44,089
+4,070
+10% +$359K 0.27% 79
2014
Q3
$3.5M Sell
40,019
-29,462
-42% -$2.66M 0.24% 88
2014
Q2
$6.11M Sell
69,481
-5,896
-8% -$511K 0.41% 67
2014
Q1
$6.36M Sell
75,377
-11,506
-13% -$918K 0.45% 66
2013
Q4
$6.82M Sell
86,883
-13,410
-13% -$1.14M 0.49% 59
2013
Q3
$8.54M Buy
100,293
+14,525
+17% +$1.22M 0.68% 47
2013
Q2
$7.38M Buy
+85,768
New +$7.12M 0.62% 50

Other funds holding LH

Clifford Swan Investment Counsel's LH Position: Q1 2026 in Review

Clifford Swan Investment Counsel reduced its Labcorp (LH) stake by 1.1% in Q1 2026, selling an estimated $308K and leaving 103,217 shares worth $27.5M. The position accounts for 0.94% of the portfolio, ranked #32.

Clifford Swan Investment Counsel first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.5M in Q3 2025. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Clifford Swan Investment Counsel held 103,217 shares of Labcorp worth $27.5M as of Q1 2026.
  • Clifford Swan Investment Counsel sold 1,136 Labcorp shares in Q1 2026, an estimated $308K.
  • Labcorp made up 0.94% of Clifford Swan Investment Counsel's portfolio in Q1 2026, its #32 holding.
  • Clifford Swan Investment Counsel first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Clifford Swan Investment Counsel's Labcorp position peaked at $30.5M in Q3 2025.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.